phrykt

CVRx, Inc. (CVRX): who owns it and who trades it

As of Nov 16, 2026, CVRX insiders reported 10 open-market sales worth $381K and 3 purchases worth $377K in the last 12 months, with 34% of the sale value made under pre-set 10b5-1 plans. The largest seller was Johnson & Johnson Innovation - JJDC, Inc. (10% owner), with $160K. 3 of the 50 famous funds we follow held it at their last quarter end.

Latest filing Nov 16, 2026. From Form 4, 13F and Schedule 13D/G filings.

At a glance

Who is buying and selling CVRx

From the latest filings

Overall: more buying than selling. Famous investors mostly bought. Funds and insiders were close to even.

Mostly sellingEvenMostly buying

Each group counts equally in the meter, by the number of buyers and sellers, not dollars. Insider sales under pre-set 10b5-1 plans are left out of it. From SEC, House and Senate filings; not advice.

Who owns CVRX

88 funds and institutions reported CVRX shares worth $78.9M at the end of Q2 2026, about 58% of the company. The largest holder is Johnson & Johnson with 15.2%.

Funds and institutions (13F) 58%Everyone else 42%

10 largest owners, by share of the company

Johnson & Johnson15.2%
NEA Management Company, LLC7.4%
BlackRock, Inc.4.7%
Royal Bank of Canada4.6%
GSK plc3.8%
Vanguard Capital Management LLC3.4%
Silvercrest Asset Management Group LLC3.3%
Geode Capital Management, LLC1.7%
PFM Health Sciences, LP1.4%
State Street Corp1.4%

Top 20 owners

OwnerShares% of companyValueChange since Q1 2026
Johnson & Johnson4.02M15.17%$20.7MNo change
NEA Management Company, LLC1.95M7.37%$10M-4%
BlackRock, Inc.1.25M4.69%$6.4M+21%
Royal Bank of Canada1.23M4.65%$6.3M+74%
GSK plc1.01M3.80%$5.2MNo change
Vanguard Capital Management LLC910,5763.43%$4.7M-0%
Silvercrest Asset Management Group LLC878,1093.31%$4.5M+54%
Geode Capital Management, LLC440,7861.66%$2.3M+3%
PFM Health Sciences, LP369,5721.39%$1.9MNew
State Street Corp366,3521.38%$1.9M+5%
Renaissance Technologies LLC230,0000.87%$1.2M+1092%
UBS Group AG224,2330.85%$1.2M+116%
Tudor Investment Corp Et Al205,6840.78%$1.1M+4%
Goldman Sachs Group Inc149,5090.56%$768K-26%
Morgan Stanley144,9770.55%$745K+4%
Kestra Advisory Services, LLC132,4000.50%$681K+176%
Two Sigma Investments, LP132,3980.50%$681K+16%
Vanguard Fiduciary Trust Co128,9550.49%$663K+1%
Dimensional Fund Advisors LP127,9710.48%$660K+143%
Northern Trust Corp124,7670.47%$641K-17%

From the SEC 13F data sets: every fund manager with over $100M must report its US stock holdings every 3 months, up to 45 days after the quarter ends. Owners are shown as they file, so one group (for example Vanguard) can appear under several names. Individuals, most insiders and smaller funds do not file 13F reports.

Insider trades

In the last 12 months, CVRX insiders reported $377K of open-market purchases and $381K of sales. 34% of the sale value was under a 10b5-1 plan, a schedule set up in advance.

Purchases, 12 months
$377K
3 trades, 2 people
Sales, 12 months
$381K
10 trades, 8 people
Sales under a 10b5-1 plan
34%
Share of sale value
Latest trade
Aug 13, 2026
Filed Aug 13, 2026

Purchases and sales by month

$300K$300KDecFebAprJunAugOct
Purchases Sales Click a bar to show only that month below

Latest trades

DateInsiderRoleTypeSharesPriceValueFiling
Aug 13, 2026Brent BinkowskiCHIEF OPERATING OFFICERPurchase26,223$2.91$76.3KForm 4
Aug 12, 2026Brent BinkowskiCHIEF OPERATING OFFICERSale plan1,309$2.55$3.3KForm 4
Mar 2, 2026Philip B. AdamsonChief Medical OfficerSale plan1,262$7.90$10KForm 4
Mar 2, 2026Kevin HykesCEOSale plan7,763$7.90$61.3KForm 4
Mar 2, 2026Paul VerrastroCHIEF MKTG & STRAT OFFICSale plan1,284$7.90$10.1KForm 4
Mar 2, 2026Jared OasheimCFOSale plan1,744$7.90$13.8KForm 4
Mar 2, 2026Robert Allen JohnChief Revenue OfficerSale plan3,964$7.90$31.3KForm 4
Feb 20, 2026Mudit K. JainDirectorPurchase46,800$6.36$298KForm 4
Feb 18, 2026Mudit K. JainDirectorPurchase600$4.64$2.8KForm 4
Nov 26, 2025& Johnson Johnson +110% ownerSale6,337$10.03$63.6KForm 4
Nov 25, 2025Johnson & Johnson Innovation - JJDC, Inc. +110% ownerSale16,000$10.03$160KForm 4
Nov 24, 2025& Johnson Johnson +110% ownerSale2,200$10.06$22.1KForm 4
Nov 21, 2025& Johnson Johnson +110% ownerSale500$10.00$5KForm 4

Insiders by value traded

InsiderRoleBoughtSoldLast trade
Mudit K. JainDirector$300K–Feb 20, 2026
Johnson & Johnson Innovation - JJDC, Inc.10% owner–$160KNov 25, 2025
& Johnson Johnson10% owner–$90.7KNov 26, 2025
Brent BinkowskiCHIEF OPERATING OFFICER$76.3K$3.3KAug 13, 2026
Kevin HykesPRES & CEO, Director–$61.3KMar 2, 2026
Robert Allen JohnChief Revenue Officer–$31.3KMar 2, 2026
Jared OasheimCHIEF FINANCIAL OFFICER–$13.8KMar 2, 2026
Paul VerrastroCHIEF MKTG & STRAT OFFICER–$10.1KMar 2, 2026
Philip B. AdamsonChief Medical Officer–$10KMar 2, 2026
What this data shows, and what it doesn't
  • Shows: open-market purchases and sales by officers, directors and 10%+ owners, reported on Form 4 within two business days of the trade.
  • Leaves out: stock awards, option exercises, shares withheld for tax and gifts. These are not trades at a market price chosen by the insider.
  • "plan" marks a sale made under a Rule 10b5-1 plan, a schedule set up in advance.
  • Fund holders come from 13F reports, a snapshot at quarter end filed up to 45 days later.
  • Filings are self-reported and can be amended. Each trade links to its original filing. Methodology

CVRX short interest

Moderate short interest. 6.4% of CVRX shares are sold short: about 1 share in 16. Over the last 12 reports the number of shares short went down 5%.

As a rough guide, under 5% is low, 5–10% is moderate, 10–20% is high and over 20% is very high.

0%5%10%15%20%+

As of Oct 30, 2026, 1.82M CVRX shares were sold short, 6.4% of the shares outstanding, down 14.9% from the report before. At the average daily volume of 341,489 shares, buying them all back would take about 5.3 trading days (days to cover).

Shares short, % of all shares

6.39%May 15Oct 309.25%

Days to cover

5.3May 15Oct 3010.1

Every report

Settlement dateShares short% of sharesChangeAvg daily volumeDays to cover
Oct 30, 20261.82M6.39%-15%341,4895.3
Oct 15, 20262.14M8.02%+8%691,0693.1
Sep 30, 20261.98M7.44%+21%826,0362.4
Sep 15, 20261.64M6.17%-17%631,1002.6
Aug 31, 20261.97M7.39%-16%815,0562.4
Aug 14, 20262.36M8.85%+17%2.54M1.0
Jul 31, 20262.01M7.54%+4%253,2827.9
Jul 15, 20261.93M7.26%+5%216,5198.9
Jun 30, 20261.84M6.93%+5%343,3405.4
Jun 15, 20261.76M6.62%-10%289,7756.1
May 29, 20261.94M7.33%+2%260,4577.5
May 15, 20261.91M7.18%+9%474,1494.0

Short sellers borrow shares and sell them, hoping to buy them back for less. A high number means many such bets are open. It does not say where the price will go. Source: FINRA equity short interest, reported by brokers twice a month (positions on the 15th and the last business day) and published about 7 business days later. % of shares uses the share count on the company's latest SEC filing. What short interest means · Most shorted stocks

CVRx company events

CVRx filed 12 reports on Form 8-K in the last 12 months, 4 of them about an important change (leadership). The latest was on Nov 5, 2026.

  1. Nov 5, 2026ResultsReleased financial results. Filing
  2. Sep 21, 2026LeadershipCVRx, Inc. announced that its Board of Directors appointed John Landry as Chief Financial Officer. Filing
  3. Aug 11, 2026LeadershipThe employment of Robert John, the Chief Revenue Officer of CVRx, Inc., terminated effective immediately, under circumstances entitling him to severance pay and benefits under his employment agreement, subject to the conditions therein. Filing
  4. Aug 6, 2026ResultsReleased financial results. Filing
  5. Jun 9, 2026LeadershipJared Oasheim, the Chief Financial Officer of CVRx, Inc., gave notice of his intention to resign from the Company to pursue other professional opportunities. Filing
  6. Jun 3, 2026VoteReported shareholder vote results. Filing
  7. May 11, 2026ResultsReleased financial results. Filing
  8. Apr 13, 2026AnnouncementAs disclosed above, on April 13, 2026, the Company issued a press release announcing certain preliminary financial results for the first quarter ended March 31, 2026, and provided information about reimbursements and its BENEFIT-HF trial . First Quarter 2026 Total revenue for the first quarter of… Filing
  9. Mar 3, 2026LeadershipAt the same time as the Compensation Committee of the Board of Directors of CVRx, Inc. approved annual equity awards for the Company’s executive officers, the Committee also approved an incremental equity award in the form of performance stock units specific to a cumulative revenue goal for the… Filing
  10. Feb 12, 2026ResultsReleased financial results. Filing
  11. Jan 12, 2026AgreementCVRx, Inc. entered into an Open Market Sale Agreement SM with Jefferies LLC. Filing
  12. Jan 12, 2026AgreementCVRx, Inc. entered into an amendment to its existing Loan and Security Agreement dated October 31, 2022, as previously amended on March 13, 2023 (as amended, the “Loan Agreement”), among the Company, Innovatus Life Sciences Fund I, LP, as the collateral agent and a lender, and the other lenders… Filing

From 8-K reports, which a company must file within 4 business days of an important event. Where a report is about a change such as a new CEO, the sentence is the first one from the report itself, shortened. Each row links to the original filing. Company events this week

CVRx financials

Famous investors that hold CVRX

3 of the 50 well-known investors we track reported holding CVRX in their latest 13F filing. The largest position is Ken Griffin's, worth $1.1M.

Position size

All holders

FundQuarterSharesValueOf portfolioChange
Ken Griffin · Citadel AdvisorsQ3 2026652,362$1.1M0.0%+726%
Jim Simons · Renaissance TechnologiesQ3 2026435,400$762K0.0%+89%
Paul Tudor Jones · Tudor Investment CorpQ3 2026208,058$364K0.0%+1%

From 13F reports: a snapshot at quarter end, filed up to 45 days later. Change compares with the quarter before.

5%+ stakes filed in the last 120 days

Anyone who owns more than 5% of a company must report it on Schedule 13D or 13G. 2 filings named CVRX in the last 120 days.

FiledHolderFormStake
Oct 2, 2026Chernett Jorey13D/A0.6%
Oct 2, 2026Chernett Jorey13D/A0.6%

Questions about CVRx, Inc. (CVRX) stock

Who owns the most CVRX stock?

The largest reported owner of CVRx, Inc. (CVRX) is Johnson & Johnson, with 15.2% of the company. In total, 88 funds and institutions reported holding CVRX at the end of Q2 2026, together about 58% of the shares. See the largest owners.

Are CVRX insiders buying or selling?

In the last 12 months, CVRX insiders reported 3 open-market purchases worth $377K and 10 sales worth $381K. The latest trade was on Aug 13, 2026. See every trade.

What is the short interest in CVRX?

As of Oct 30, 2026, 1.82M CVRX shares were sold short, 6.4% of the shares outstanding, down 14.9% from the report before. At the average daily volume of 341,489 shares, buying them all back would take about 5.3 trading days (days to cover). See the history.

Which famous investors hold CVRX?

3 of the 50 well-known investors we track reported CVRX in their latest 13F filing, including Ken Griffin, Jim Simons, Paul Tudor Jones. The largest position is worth $1.1M. See all holders.

Source: SEC Form 4 (insiders, filed within 2 business days), 13F (funds, up to 45 days after quarter end) and Schedule 13D/13G filings. Only open-market purchases (code P) and sales (code S) are shown. Data only, not investment advice. How we collect it.